Patents by Inventor Eric Paul Krenning

Eric Paul Krenning has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RGD (Arg-Gly-Asp) coupled to (neuro)peptides
    Patent number: 7202330
    Abstract: The invention relates to compounds having a binding affinity for both the ?v?3 receptor and a (neuro)peptide receptor, in particular the somatostatin receptor, which compound comprises a first peptide part comprising at least once the amino acid sequence Arg-Gly-Asp, and a second peptide part coupled thereto, optionally via a linker, which second peptide part is a (neuro)peptide.
    Type: Grant
    Filed: April 26, 2001
    Date of Patent: April 10, 2007
    Assignee: BioSynthema Inc.
    Inventors: Marion DeJong, Eric Paul Krenning, Petrus Martinus Van Hagen
  • Rgd (arg-gly-asp) coupled to (neuro)peptides
    Publication number: 20040136907
    Abstract: The invention relates to compounds having a binding affinity for both the &agr;v&bgr;3 receptor and a (neuro)peptide receptor, in particular the somatostatin receptor, which compound comprises a first peptide part comprising at least once the amino acid sequence Arg-Gly-Asp, and a second peptide part coupled thereto, optionally via a linker, which second peptide part is a (neuro)peptide.
    Type: Application
    Filed: February 24, 2003
    Publication date: July 15, 2004
    Inventors: Marion DeJong, Eric Paul Krenning, Petrus Martinus Van Hagen
  • Therapeutic use of somatostatin peptides
    Patent number: 6123916
    Abstract: The invention relates to a new pharmaceutical use of somatostatin peptides comprising on the terminal amino group a polyamino polycarboxylic group, in free form or in a pharmaceutically acceptable salt form, particularly in the manufacture of a medicament for treating disorders with an aetiology comprising or associated with excess of GH-secretion.
    Type: Grant
    Filed: June 13, 1994
    Date of Patent: September 26, 2000
    Assignee: Novartis AG
    Inventors: Eric Paul Krenning, Steven Willem Jan Lamberts